2011
DOI: 10.1007/s11910-011-0196-9
|View full text |Cite
|
Sign up to set email alerts
|

Hormonal Therapy for Epilepsy

Abstract: In 2011, there are greater than 20 antiepileptic medications available. These medications work by modulating neuronal excitability. Reproductive hormones have been found to have a role in the pathogenesis and treatment of seizures by also altering neuronal excitability, especially in women with catamenial epilepsy. The female reproductive hormones have in general opposing effects on neuronal excitability; estrogens generally impart a proconvulsant neurophysiologic tone, whereas the progestogens have anticonvul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 40 publications
0
12
0
1
Order By: Relevance
“…On the other hand, 5α-DHP inhibited both components of seizures (Lonsdale et al, 2006). Growing evidence suggests that anticonvulsive and neuroprotective properties of PROG are mediated by its metabolites 5α-DHP and ALLO, positive modulators of GABA A receptors (Reddy, 2004; Ciriza et al, 2006; Verrotti et al, 2010; Stevens and Harden, 2011). ALLO itself protected against picrotoxin-induced neuronal cell death (Brinton, 1994).…”
Section: Progesterone and Derivativesmentioning
confidence: 99%
“…On the other hand, 5α-DHP inhibited both components of seizures (Lonsdale et al, 2006). Growing evidence suggests that anticonvulsive and neuroprotective properties of PROG are mediated by its metabolites 5α-DHP and ALLO, positive modulators of GABA A receptors (Reddy, 2004; Ciriza et al, 2006; Verrotti et al, 2010; Stevens and Harden, 2011). ALLO itself protected against picrotoxin-induced neuronal cell death (Brinton, 1994).…”
Section: Progesterone and Derivativesmentioning
confidence: 99%
“…However, in men, androgen ablation therapy for prostate cancer leads to few or no significant deficits in cognitive performance (Nelson et al, 2008; Alibhai et al, 2010a; Alibhai et al, 2010b; Matousek and Sherwin, 2010). The reduced levels of androgens in aging men are often considered to be a contributing factor to diseases that increase with age such as Alzheimer’s disease (Fuller et al, 2007; Drummond et al, 2009; Barron and Pike, 2011; Luchetti et al, 2011), epilepsy (Herzog, 1991; Harden and MacLusky, 2004; 2005; Frye, 2006; Reddy, 2010; Stevens and Harden, 2011) and Parkinson’s disease (Al Sweidi et al, 2011). However, direct evidence in support of this idea, such as prevention of these diseases by androgen therapy, is generally weak, although androgens ameliorate symptoms in some instancess (Herzog, 1991; Almeida and Flicker, 2003; Cherrier et al, 2005; Harden and MacLusky, 2005; Driscoll and Resnick, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Growing evidence suggests that anticonvulsive and neuroprotective properties of PROG are mediated by its metabolites 5α-DHP and ALLO, positive modulators of GABAA receptors (Stevens & Harden, 2011).…”
Section: Progesterone and Derivativesmentioning
confidence: 99%